Major Depressive Disorder (MDD), commonly known as depression, is a significant mental health condition characterized by persistent and intense feelings of sadness, hopelessness, and a lack of interest or pleasure in activities. These symptoms go beyond normal fluctuations in mood and temporary emotional responses to challenges in everyday life.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
Major Depressive Disorder (MDD) is a prevalent and often misunderstood mental health condition. MDD, typically referred to as depression, is more than just occasional feelings of sadness or low mood and impacts millions of individuals worldwide. It is critical to those who have been affected by MDD that more light be shed on this topic to foster a community of understanding and resilience.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...